Information:
Fel:
ID
31570
Beskrivning
A Dose Finding Study With I.V. Panobinostat (LBH589), Docetaxel, and Prednisone in Patients With Hormone Refractory Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00663832
Länk
https://clinicaltrials.gov/show/NCT00663832
Nyckelord
Versioner (1)
- 2018-09-05 2018-09-05 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
5 september 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Prostate Cancer NCT00663832
Eligibility Prostate Cancer NCT00663832
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT00663832
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Hormone refractory prostate cancer
Item
hrpc patients
boolean
C1328504 (UMLS CUI [1])
Disease Progression
Item
evidence of disease progression
boolean
C0242656 (UMLS CUI [1])
Self care | Ability Performance Light Work
Item
self care, able to perform light work activities
boolean
C3872897 (UMLS CUI [1])
C0085732 (UMLS CUI [2,1])
C0597198 (UMLS CUI [2,2])
C2987220 (UMLS CUI [2,3])
C0085732 (UMLS CUI [2,1])
C0597198 (UMLS CUI [2,2])
C2987220 (UMLS CUI [2,3])
Contraceptive methods Willing
Item
willing to use contraception throughout the study and for 12 weeks after study completion
boolean
C0700589 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
C0600109 (UMLS CUI [1,2])
Cancer Other Disease length | Curative treatment Absent
Item
history of other cancers not curatively treated with no evidence of disease for more than 5 years.
boolean
C1707251 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C1273390 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0872146 (UMLS CUI [1,2])
C1273390 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Prior radiation therapy
Item
prior radiotherapy within 3 weeks of starting study treatment
boolean
C0279134 (UMLS CUI [1])
Radiopharmaceuticals | Strontium | Samarium
Item
prior radiopharmaceuticals (strontium, samarium).
boolean
C0182638 (UMLS CUI [1])
C0038467 (UMLS CUI [2])
C0036147 (UMLS CUI [3])
C0038467 (UMLS CUI [2])
C0036147 (UMLS CUI [3])
Decreased cardiac function
Item
impaired cardiac function
boolean
C0232166 (UMLS CUI [1])
Heart Disease
Item
heart disease
boolean
C0018799 (UMLS CUI [1])
Liver disease | Kidney Disease | Liver Dysfunction | Renal Insufficiency
Item
liver or renal disease with impaired functions.
boolean
C0023895 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
C0086565 (UMLS CUI [3])
C1565489 (UMLS CUI [4])
C0022658 (UMLS CUI [2])
C0086565 (UMLS CUI [3])
C1565489 (UMLS CUI [4])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])